Related Experiment Video
Updated: Jun 29, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Hydroxyurea inhibits thymidine kinase activity in developing rat cerebellum
Summary
Hydroxyurea significantly inhibited thymidine kinase activity in rat cerebellum, suggesting its DNA synthesis inhibition involves multiple sites beyond ribonucleotide reductase. This effect was dose and time-dependent.
Area of Science:
- Biochemistry
- Pharmacology
- Neuroscience
Background:
- Hydroxyurea is a known inhibitor of DNA synthesis.
- Its primary mechanism is often attributed to ribonucleotide reductase inhibition.
- The role of other enzymes in hydroxyurea's effects requires further investigation.
Purpose of the Study:
- To investigate the effect of hydroxyurea on thymidine kinase activity in rat cerebellum.
- To determine if hydroxyurea's inhibition of DNA synthesis involves thymidine kinase.
- To explore the dose and time dependency of hydroxyurea's effects.
Main Methods:
- Intraperitoneal injection of hydroxyurea in rats (single and multiple doses).
- Assay of thymidine kinase activity in cerebellar tissue on the 7th day post-injection.
- In vitro testing of hydroxyurea's effect on thymidine kinase activity.
Main Results:
- Hydroxyurea markedly inhibited cerebellar thymidine kinase activity.
- The inhibition was both dose and time dependent.
- No inhibitory effect was observed when hydroxyurea was added directly to the reaction mixture in vitro.
Conclusions:
- Hydroxyurea's inhibition of DNA synthesis may involve mechanisms beyond ribonucleotide reductase.
- Thymidine kinase is a potential target for hydroxyurea's inhibitory action.
- In vivo administration is crucial for observing hydroxyurea's effects on thymidine kinase.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

